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Abstract 
In this work we present an efficient, environmentally friendly approach to the 
synthesis of a series of hyodeoxycholic acid derivatives applying Biocatalysis. Fifteen 
acetyl and ester derivatives, twelve of them new, were obtained through an enzymatic 
strategy in a fully regioselective way and in very good to excellent yield. In order to find 
the optimal reaction conditions, the influence of several parameters such as enzyme source, 
alcohol or acylating agent:substrate ratio, enzyme:substrate ratio, temperature and reaction 
solvent was considered. The excellent results obtained made this procedure very efficient, 
particularly considering the low amount of enzyme required. In addition, this methodology 
uses mild reaction conditions and has reduced environmental impact, making biocatalysis a 
suitable way to obtaining these bile acids derivatives.  
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1. Introduction 
Bile acids are found predominantly in the bile of mammals and other vertebrates as 
oxygenated metabolites of steroids [1, 2]. They are classified in two groups: primary bile 
acids (cholic, CA, and chenodeoxycholic, CDCA) which are synthesized by the liver, and 
secondary bile acids which are obtained through enterobacterial metabolism of primary bile 
acids, such as deoxycholic (DCA), lithocholic (LCA), and hyodeoxycholic (HDCA) acids 
(Scheme 1). 
 
 
Scheme 1. Structure of important bile acids 
 
Bile acids are important metabolites that take part in many biological processes such as 
secretion, digestion and regulation of cholesterol metabolism. Therefore, they are the 
subject of several pharmacological studies [1, 3, 4]. Because of their amphiphilic properties 
they act as biological detergents that help in the absorption and dissolution of fatty acids 
and vitamins. Also, they show many pharmacological properties, including selective and 
potent farnesoid X receptor (FXR) antagonism [5], antimicrobial [6] and anticarcinogenic 
activity [7, 8]. In addition, they show promising activity for the treatment of various 
inflammation-related human diseases [9]. For these reasons, bile acid analogs are 
extensively used in drug formulations in order to improve absorption [10, 11], as excipients 
that can enhance transdermal penetration [12, 13], gastrointestinal solubility and stability of 
drugs [14, 15] and bring multiple benefits. Hyodeoxycholic acid (HDCA, 5) is the main 
acid constituent of hog bile, and for many years it was used in the industry as a precursor in 
the synthesis of steroids. Moreover, HDCA has proved to inhibit atherosclerosis in mice by 
decreasing cholesterol levels [16].  
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Highly active and selective biocatalysts such as enzymes and whole cells are very powerful 
tools in organic synthesis, behaving in a chemo-, regio- and enantioselective way, 
simplifying the preparation of a wide variety complex organic molecules [17, 18]. 
Moreover, at the present time chemoenzymatic multi-step processes are a growing subject 
in organic synthesis [19], especially for the synthesis of novel pharmaceutical derivatives 
[20]. This approach has many advantages, namely it allows to avoid tedious protection and 
deprotection steps in chemical synthesis, which is especially useful when working with 
compounds with several functional groups. 
Amid the wide variety of enzymes used in organic synthesis, lipases in non-aqueous media 
have an amazing promiscuity, being used for a broad range of reactions such as aminolysis, 
esterification, transesterification, polymerization, etc. [21-25]. In our laboratory several 
studies have been accomplished on the use of lipases, obtaining a wide variety of 
biologically active compounds, many of them new [26-35]. 
Usually, the potential application of bile acids depends on their amphiphilic properties, 
therefore we have recently studied and reported the synthesis of derivatives of many bile 
acids searching for an increase in its lipophilicity [28, 36, 37]. We described the application 
of lipases to the esterification, acetylation and alcoholysis of CDCA, DCA, LCA and CA. 
Candida antarctica B lipase gave the best results for esterification and acetylation reactions 
of CDCA, DCA and LCA and for alcoholysis reaction of the four bile acids. CA showed a 
different behavior in comparison with the other bile acids, probably due to its structure 
containing three hydroxyl groups. In the case of CA, Rhizomucor miehei lipase gave the 
best results for the esterification reaction, but it was not possible to obtain acetylation 
products with any of the lipases tested. 
Continuing with this approach, we noticed that compared to the other bile acids, there are 
very few works about hyodeoxycholic acid (HDCA). Therefore, we thought it would be of 
great interest to analyze its reactivity and obtain different derivatives which might have 
useful applications. In the present work we present the synthesis of a series of derivatives of 
hyodeoxycholic acid, most of them new, obtained by lipase-catalyzed esterification, 
acetylation and alcoholysis reactions.  
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2. Experimental 
2.1. General 
Chemicals and solvents were purchased from Merck Argentina and Sigma–Aldrich de 
Argentina and used without further purification. Lipase from Candida rugosa (CRL) (905 
U/mg solid) was purchased from Sigma Chemical Co.; Candida antarctica lipase B (CAL 
B): Novozym 435 (7400 PLU/g), Lipozyme from Thermomyces lanuginosus (TLIM) and 
Lipozyme from Rhizomucor miehei RM1M (LIP) (both 7800 U/g) were generous gifts of 
Novozymes Spain; Carica papaya lipase (CPL) is the remaining solid fraction of papaya 
latex, after wash off of proteases using distilled water. CPL is a naturally immobilized 
enzyme [38] and was a generous gift of Dr. Georgina Sandoval, CIATEJ, Mexico. All 
enzymes were used "straight from the bottle". Enzyme/substrate ratio (E/S): enzyme 
amount in mg/substrate amount in mg. Enzymatic reactions were carried out on MaxQ 
4000 Thermo Scientific Co. digital incubator shaker at the corresponding temperature and 
200 rpm. To monitor the reaction progress aliquots were withdrawn and analyzed by TLC 
performed on commercial 0.2 mm aluminum-coated silica gel plates (F254) and visualized 
by immersion in an aqueous solution of (NH4)6Mo7O24.4H2O (0.04 M), Ce(SO4)2 (0.003 
M) in H2SO4 (10%). % Conversion was determined by analytical reverse phase HPLC 
employing a Phenomenex Phenogel column 5 M 10E5A, 300 x 7.8 mm and eluting with 
MeOH:H2O 80:20 at 1.00 mL/min. 
1H NMR and 13C NMR spectra were recorded at room 
temperature in CDCl3 as solvent using a Bruker AM-500 NMR instrument operating at 
500.14 MHz and 125.76 MHz for 1H and 13C respectively. The 1H NMR spectra are 
referenced to the residual CHCl3 proton of the solvent CDCl3 at  = 7.26 ppm. Coupling 
constants are reported in Hertz (Hz). 13C NMR spectra were fully decoupled and are 
referenced to the middle peak of the solvent CDCl3 at  = 77.0 ppm. Splitting patterns are 
designated as: s, singlet; d, doublet; t, triplet; q, quadruplet; dd, double doublet, etc. High 
Resolution Mass Spectrometry was recorded with Thermo Scientific EM/DSQ II – DIP. 
The results were within ±0.02% of the theoretical values. 
 
2.2. Lipase-catalyzed esterification. General procedure 
LIP (10 mg) was added to a solution of hyodeoxycholic acid (20 mg) and the corresponding 
alcohol (1 eq.) in diisopropyl ether (DIPE) (5 mL). The suspension was shaken (200 rpm) 
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at 55 ºC and the reaction monitored by TLC. Once the reaction was finished, the enzyme 
was filtered off and the solvent evaporated under reduced pressure. The residue was 
purified by column chromatography on silica gel employing mixtures of hexane:ethyl 
acetate as eluent (1:0-1:1). Reuse experiments: the filtered and washed enzyme was used in 
the next enzymatic esterification under the same reaction conditions. LIP retained 80 % 
activity after three reaction cycles. 
 
2.3. Lipase-catalyzed acetylation. 
CAL B (10 mg) was added to a solution of hyodeoxycholic acid (20 mg) in ethyl acetate (5 
mL). The suspension was shaken (200 rpm) at 55 ºC and the progress of the reaction 
monitored by TLC. Once the reaction finished, the enzyme was filtered off and the solvent 
evaporated under reduced pressure. Given that the reaction achieved full conversion no 
further purification was needed. Reuse experiments: the filtered and washed enzyme was 
used in the next enzymatic acetylation under the same reaction conditions. CAL B retained 
95 % activity after five reaction cycles. 
 
2.4. Lipase-catalyzed alcoholysis. 
CAL B (1 g) was added to a solution of 3,6-diacetoxy hyodeoxycholic acid (50 mg) in 10 
ml of hexane containing 1.2 mol equiv. of ethanol. The suspension was shaken (200 rpm) at 
55 °C and the progress of the reaction was monitored by TLC. When the reaction finished, 
lipase was filtered off, the solvent was evaporated under reduced pressure, and the crude 
residue purified by column chromatography on silica gel employing mixtures hexane:ethyl 
acetate as eluent (4:1-1:1). 
 
2.5. Chemical peracetylation 
A mixture of hyodeoxycholic acid (100 mg), acetic anhydride (2 mL) and pyridine (2 mL) 
was stirred at room temperature for 16 hs. TLC was used to monitor the development of the 
reaction. After completion, the mixture was partitioned using ammonium chloride saturated 
solution (10 mL) and methylene chloride (10 mL). The aqueous phase was extracted with 
methylene chloride (3 x 10 mL). Afterwards, the combined organic layers were washed 
with sodium chloride saturated solution (5 x 10 mL), dried using anhydrous MgSO4, and 
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the solvent was evaporated. The residue (125 mg) was purified by column chromatography 
(silica gel) employing mixtures of hexane/EtOAc as eluent (4:1–1:1) (7, m = 110 mg). 
Ethyl hyodeoxycholate (6a): Yield 95%; colorless oil; 1H NMR (CDCl3, 500 MHz) 4.07 
(2H, q, J = 6.8 Hz, -OCH2CH3), 3.96 (1H, dt, J = 12.2, 5.0 Hz, H-6), 3.53 (1H, m, H-3), 
2.27 (1H, m, H-23b), 2.16 (1H, m, H-23a), 1.21 (3H, t, J = 6.8 Hz, -OCH2CH3), 0.86 (3H, 
d, J = 6.4 Hz, H-21), 0.85 (3H, s, H-19), 0.60 (3H, s, H-18); 13C NMR (CDCl3, 500 MHz) 
174.6 (C-24), 71.2 (C-6), 67.8 (C-3), 60.2 (-OCH2CH3), 56.0, 55.8, 48.2, 42.7, 39.8, 39.7, 
35.8, 35.4, 35.2, 34.7, 31.2, 31.1, 30.9, 29.8, 29.6, 28.0, 24.1 (C-19), 23.4, 20.6, 18.1 (C-
21), 14.1 (-OCH2CH3), 11.9 (C-18). HRMS: [M + Na]
+ Calcd. C26H44NaO4 443.3137. 
Found: C26H44NaO4 443.3139. 
n-Propyl hyodeoxycholate (6b): Yield 90%; colorless oil; 1H NMR (CDCl3, 500 MHz) 
4.06 (1H, dt, J = 12.1, 5.3 Hz, H-6), 4.02 (2H, t, J = 6.65 Hz, -OCH2CH2CH3), 3.62 (1H, 
m, H-3), 2.34 (1H, m, H-23b), 2.21 (1H, m, H-23a), 1.13 (3H, d, J = 6.2 Hz, H-21), 0.93 
(3H, t, J = 7.1 Hz, -OCH2CH2CH3), 0.89 (3H, s, H-19), 0.63 (3H, s, H-18); 
13C NMR 
(CDCl3, 500 MHz) 174.5 (C-24), 71.6 (C-6), 68.1 (C-3), 65.9 (-OCH2CH2CH3), 56.1, 
55.9, 48.3, 42.8, 39.9, 39.8, 35.9, 35.5, 35.3, 35.0, 31.3, 31.0, 30.2, 29.1, 28.1, 24.2 (C-19), 
23.5, 22.9, 22.0, 20.7, 18.2 (C-21), 12.0 (-OCH2CH2CH3), 10.4 (C-18). HRMS: [M + Na]
+ 
Calcd. C27H46NaO4 457.3294. Found: C27H46NaO4 457.3287. 
n-Butyl hyodeoxycholate (6c): Yield 82% after two purifications by column 
chromatography; colorless oil; 1H NMR (CDCl3, 500 MHz) 4.10 (1H, q, J = 6.1 Hz, H-6), 
4.04 (2H, t, J = 6.7 Hz, -OCH2CH2CH2CH3), 3.62 (1H, tt, J = 11.2, 6.3 Hz, H-3), 2.32 (1H, 
m, H-23b), 2.21 (1H, m, H-23a), 0.93 (3H, t, J = 6.8 Hz, -OCH2CH2CH2CH3), 0.91 (3H, d, 
J = 6.7 Hz, H-21), 0.90 (3H, s, H-19), 0.63 (3H, s, H-18); 13C NMR (CDCl3, 500 MHz) 
174.4 (C-24), 71.6 (C-6), 68.1 (C-3), 64.1 (-OCH2CH2CH2CH3), 56.1, 55.9, 48.4, 42.8, 
40.0, 39.8, 35.9, 35.5, 35.3, 35.0, 34.8, 31.3, 31.0, 30.7, 30.2, 29.2, 28.1, 24.2 (C-19), 23.5, 
20.8, 19.2, 18.2 (C-21), 13.7 (-OCH2CH2CH2CH3), 12.0 (C-18). HRMS: [M + Na]
+ Calcd. 
C28H48NaO4 471.3450. Found: C28H48NaO4 471.3453. 
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n-Pentyl hyodeoxycholate (6d): Yield 80% after two purifications by column 
chromatography; colorless oil; 1H NMR (CDCl3, 500 MHz) 4.06 (2H, t, J = 6.8 Hz, 
OCH2CH2CH2CH2CH3), 4.04 (1H, dt, J = 11.7, 6.8 Hz, H-6), 3.62 (1H, tt, J = 11.1, 6.5 Hz, 
H-3), 2.32 (1H, m, H-23b), 2.22 (1H, m, H-23a), 0.94 (3H, t, J = 7.4 Hz, -
OCH2CH2CH2CH2CH3), 0.90 (3H, d, J = 7.3 Hz, H-21), 0.89 (3H, s, H-19), 0.64 (3H, s, H-
18); 13C NMR (CDCl3, 500 MHz) 174.4 (C-24), 71.6 (C-6), 68.1 (C-3), 64.4 (-
OCH2CH2CH2CH2CH3), 56.1, 55.9, 48.4, 42.8, 39.9, 39.8, 35.9, 35.5, 35.3, 35.1, 34.8, 
31.3, 31.0, 30.2, 29.2, 29.2, 28.4, 28.1, 24.2 (C-19), 23.5, 22.3, 20.8, 18.2 (C-21), 14.0 (-
OCH2CH2CH2CH2CH3), 12.0 (C-18). HRMS: [M + Na]
+ Calcd. C29H50NaO4 485.3607. 
Found: C29H50NaO4 485.3612. 
n-Octyl hyodeoxycholate (6e): Yield 78%; colorless oil; 1H NMR (CDCl3, 500 MHz) 
4.07 (3H, m, H-6, -OCH2(CH2)6CH3), 3.64 (1H, tt, J = 11.1, 6.5 Hz, H-3), 2.34 (1H, m, 
H-23b), 2.22 (1H, m, H-23a), 0.92 (3H, d, J = 6.9 Hz, H-21), 0.91 (3H, s, H-19), 0.90 (3H, 
t, J = 6.9 Hz, -OCH2(CH2)6CH3), 0.65 (3H, s, H-18); 
13C NMR (CDCl3, 500 MHz) 174.4 
(C-24), 71.6 (C-6), 68.1 (C-3), 64.4 (-OCH2(CH2)6CH3), 56.1, 55.9, 48.4, 42.8, 39.9, 39.8, 
35.9, 35.5, 35.3, 35.1, 34.8, 31.8, 31.3, 31.0, 30.2, 29.2 (x3), 28.7, 28.1, 26.0, 24.2 (C-19), 
23.5, 22.6, 20.8, 18.2 (C-21), 14.1 (-OCH2(CH2)6CH3), 12.0 (C-18). HRMS: [M + Na]
+ 
Calcd. C32H56NaO4 527.4076. Found: C32H56NaO4 527.4072. 
n-Lauryl hyodeoxycholate (6f): Yield 83%; colorless oil; 1H NMR (CDCl3, 500 MHz) 
4.05 (3H, m, H-6, -OCH2(CH2)10CH3), 3.61 (1H, tt, J = 11.1, 6.5 Hz, H-3), 2.32 (1H, m, 
H-23b), 2.20 (1H, m, H-23a), 0.91 (3H, d, J = 6.8 Hz, H-21), 0.90 (3H, s, H-19), 0.87 (3H, 
t, J = 6.7 Hz, -OCH2(CH2)10CH3), 0.63 (3H, s, H-18); 
13C NMR (CDCl3, 500 MHz) 174.4 
(C-24), 71.6 (C-6), 68.0 (C-3), 64.5 (-OCH2(CH2)10CH3), 56.1, 55.9, 48.4, 42.8, 39.9, 39.8, 
35.9, 35.5, 35.3, 35.0, 34.9, 31.9, 31.3, 31.0, 30.2, 29.7 (x2), 29.6, 29.5, 29.4, 29.3, 29.1, 
28.7, 28.1, 25.9, 24.2 (C-19), 23.5, 22.7, 20.8, 18.2 (C-21), 14.1 (-OCH2(CH2)10CH3), 12.0 
(C-18). HRMS: [M + Na]+ Calcd. C36H64NaO4 583.4702. Found: C36H64NaO4 583.4698. 
n-Miristyl hyodeoxycholate (6g): Yield 85%; colorless oil; 1H NMR (CDCl3, 500 MHz) 
4.07 (3H, m, H-6, -OCH2(CH2)12CH3), 3.63 (1H, tt, J = 11.0, 6.2 Hz, H-3), 2.32 (1H, m, 
H-23b), 2.22 (1H, m, H-23a), 0.91 (3H, d, J = 6.7 Hz, H-21), 0.90 (3H, s, H-19), 0.87 (3H, 
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t, J = 6.5 Hz, -OCH2(CH2)14CH3), 0.63 (3H, s, H-18); 
13C NMR (CDCl3, 500 MHz) 174.6 
(C-24), 71.8 (C-6), 68.3 (C-3), 64.6 (-OCH2(CH2)12CH3), 56.3, 56.1, 48.5, 43.0, 40.1, 40.0, 
36.1, 35.7, 35.5, 35.2, 35.0, 32.1, 31.5, 31.2, 30.4, 29.9, 29.8 (x2), 29.7 (x2), 29.6, 29.5, 
29.4, 29.3, 28.8, 28.3, 26.1, 24.4 (C-19), 23.6, 22.9, 20.9, 18.4 (C-21), 14.3 (-
OCH2(CH2)12CH3), 12.2 (C-18). HRMS: [M + Na]
+ Calcd. C38H68NaO4 611.5015. Found: 
C38H68NaO4 611.5011. 
n-Palmityl hyodeoxycholate (6h): Yield 82%; colorless oil; 1H NMR (CDCl3, 500 MHz) 
4.07 (3H, m, H-6, -OCH2(CH2)14CH3), 3.64 (1H, tt, J = 11.1, 6.5 Hz, H-3), 2.34 (1H, m, 
H-23b), 2.21 (1H, m, H-23a), 0.94 (3H, d, J = 6.9 Hz, H-21), 0.92 (3H, s, H-19), 0.89 (3H, 
t, J = 6.7 Hz, -OCH2(CH2)14CH3), 0.65 (3H, s, H-18); 
13C NMR (CDCl3, 500 MHz) 174.4 
(C-24), 71.6 (C-6), 68.1 (C-3), 64.5 (-OCH2(CH2)14CH3), 56.1, 55.9, 48.4, 42.8, 39.9, 39.8, 
36.0, 35.5, 35.3, 35.1, 34.8, 31.9, 31.3, 31.0, 30.3, 29.7 (x5), 29.6 (x2), 29.5, 29.4, 29.3, 
29.2, 28.7, 28.1, 26.0, 24.2 (C-19), 23.5, 22.7, 20.7, 18.2 (C-21), 14.1 (-OCH2(CH2)14CH3), 
12.0 (C-18). HRMS: [M + Na]+ Calcd. C40H72NaO4 639.5328. Found: C40H72NaO4 
639.5331. 
n-Stearyl hyodeoxycholate (6i): Yield 80%; colorless oil; 1H NMR (CDCl3, 500 MHz) 
4.05 (3H, m, H-6, -OCH2(CH2)16CH3), 3.64 (1H, tt, J = 11.1, 6.5 Hz, H-3), 2.32 (1H, m, 
H-23b), 2.21 (1H, m, H-23a), 0.93 (3H, d, J = 6.9 Hz, H-21), 0.91 (3H, s, H-19), 0.87 (3H, 
t, J = 6.7 Hz, -OCH2(CH2)16CH3), 0.65 (3H, s, H-18); 
13C NMR (CDCl3, 500 MHz) 174.4 
(C-24), 71.6 (C-6), 68.1 (C-3), 64.5 (-OCH2(CH2)16CH3), 56.2, 56.0, 48.4, 42.9, 40.0, 39.9, 
36.0, 35.6, 35.4, 35.1, 34.9, 32.0, 31.4, 31.1, 30.3, 29.8, 29.7 (x4), 29.6 (x4), 29.5, 29.4, 
29.3, 29.2, 28.7, 28.2, 26.0, 24.2 (C-19), 23.5, 22.7, 20.8, 18.2 (C-21), 14.2 (-
OCH2(CH2)16CH3), 12.1 (C-18). HRMS: [M + Na]
+ Calcd. C42H76NaO4 667.5641. Found: 
C42H76NaO4 667.5637. 
n-Benzyl hyodeoxycholate (6j): Yield 92%; colorless oil; 1H NMR (CDCl3, 500 MHz) 
7.35 (5H, s, - CH2Ph), 5.11 (2H, s, -CH2Ph), 4.05 (1H, dt, J = 12.0, 4.8 Hz, H-6), 3.62 
(1H, tt, J = 11.4, 6.7 Hz, H-3), 2.38 (1H, m, H-23b), 2.27 (1H, m, H-23a), 0.90 (6H, t, J = 
6.9 Hz, H-19, H-21), 0.61 (3H, s, H-18); 13C NMR (CDCl3, 500 MHz) 174.2 (C-24), 
136.3 (Ph-C1), 128.7 (Ph, C2,C2’), 128.4 (Ph, C3,C3’), 128.3 (Ph, C4), 71.8 (C-6), 68.3 
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(C-3), 66.3 (-OCH2Ph), 56.3, 56.1, 48.6, 43.0, 40.1, 40.0, 36.1, 35.7, 35.5, 35.2, 35.0, 31.4, 
31.1, 30.4, 29.4, 28.3, 24.4 (C-19), 23.6, 20.9, 18.4 (C-21), 12.2 (C-18). HRMS: [M + Na]+ 
Calcd. C31H46NaO4 505.3294. Found: C31H46NaO4 505.3289. 
3-Acetoxy hyodeoxycholic acid (7): Yield 91% after two purifications by column 
chromatography; colorless oil; 1H NMR (CDCl3, 500 MHz) 4.71 (1H, tt, J = 11.2, 6.6 Hz, 
H-3), 4.07 (1H, dt, J = 11.6, 4.7 Hz, H-6), 2.37 (1H, m, H-23b), 2.25 (1H, m, H-23a), 2.02 
(3H, s, -COCH3), 0.93 (3H, d, J = 6.3 Hz, H-21), 0.91 (3H, s, H-19), 0.64 (3H, s, H-18); 
13C NMR (CDCl3, 500 MHz) 179.3 (C-24), 170.6 (-COCH3), 74.1 (C-6), 67.9 (C-3), 
56.1, 55.9, 48.2, 42.8, 39.9, 39.8, 35.9, 35.3, 35.2, 34.7 (x2), 30.9, 30.8, 28.1, 26.5, 25.3, 
24.1 (C-19), 23.4, 21.4 (-COCH3), 20.8, 18.2 (C-21), 12.0 (C-18). HRMS: [M + Na]
+ 
Calcd. C26H42NaO5 457.2930. Found: C26H42NaO5 457.2925. 
Ethyl 3-Acetoxy hyodeoxycholate (8): Yield 88% after two purifications by column 
chromatography; colorless oil; 1H NMR (CDCl3, 500 MHz) 4.73 (1H, tt, J = 11.2, 6.5 Hz, 
H-3), 4.14 (2H, q, J = 6.7 Hz, -OCH2CH3), 4.07 (1H, dt, J = 11.3, 4.7 Hz, H-6), 2.34 (1H, 
m, H-23b), 2.21 (1H, m, H-23a), 2.04 (3H, s, -COCH3), 1.27 (3H, t, J = 6.7 Hz, -
OCH2CH3), 0.93 (3H, d, J = 6.3 Hz, H-21), 0.93 (3H, s, H-19), 0.65 (3H, s, H-18); 
13C 
NMR (CDCl3, 500 MHz) 174.3 (C-24), 170.5 (-COCH3), 74.1 (C-6), 67.9 (C-3), 60.2 (-
OCH2CH3), 56.1, 56.0, 48.3, 42.8, 39.9, 39.8, 36.0, 35.3, 35.2, 34.8, 34.7, 31.3, 31.0, 28.1, 
26.5, 25.3, 24.2 (C-19), 23.4, 21.4 (-COCH3), 20.7, 18.3 (C-21), 14.3 (-OCH2CH3), 12.0 
(C-18). HRMS: [M + Na]+ Calcd. C28H46NaO5 485.3243. Found: C28H46NaO5 485.3238. 
3,6-Diacetoxy hyodeoxycholic acid (9a): Yield 89%; colorless oil; 1H NMR (CDCl3, 
500 MHz) 5.14 (1H, dt, J = 11.6, 4.7 Hz, H-6), 4.70 (1H, tt, J = 11.3, 6.4 Hz, H-3), 2.38 
(1H, m, H-23b), 2.25 (1H, m, H-23a), 2.03 (3H, s, -COCH3), 2.01 (3H, s, -COCH3), 0.97 
(3H, s, H-19), 0.92 (3H, d, J = 6.6 Hz, H-21), 0.64 (3H, s, H-18); 13C NMR (CDCl3, 500 
MHz) 179.5 (C-24), 170.5 (-COCH3), 170.5 (-COCH3), 73.7 (C-6), 71.0 (C-3), 56.1, 
55.9, 45.3, 42.9, 39.8 (x2), 36.0, 35.2, 35.0, 34.6, 31.3, 30.9, 30.7, 28.1, 26.4, 26.2, 24.1 (C-
19), 23.3, 21.4 (-COCH3), 21.4 (-COCH3), 20.7, 18.2 (C-21), 12.0 (C-18). HRMS: [M + 
Na]+ Calcd. C28H44NaO6 499.3036. Found: C28H44NaO6 499.3039. 
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Ethyl 3,6-Diacetoxy hyodeoxycholate (9b): Yield 85%; colorless oil; 1H NMR 
(CDCl3, 500 MHz) 5.15 (1H, dt, J = 12.2, 4.8 Hz, H-6), 4.71 (1H, tt, J = 11.4, 6.6 Hz, H-
3), 4.13 (2H, q, J = 6.7 Hz, -OCH2CH3), 2.34 (1H, m, H-23b), 2.23 (1H, m, H-23a), 2.05 
(3H, s, -COCH3), 2.03 (3H, s, -COCH3), 1.27 (3H, t, J = 7.0 Hz, -OCH2CH3), 0.98 (3H, s, 
H-19), 0.93 (3H, d, J = 6.5 Hz, H-21), 0.65 (3H, s, H-18); 13C NMR (CDCl3, 500 MHz) 
174.3 (C-24), 170.5 (-COCH3), 170.5 (-COCH3), 73.7 (C-6), 71.0 (C-3), 60.2 (-
OCH2CH3), 56.2, 56.0, 45.4, 42.9, 39.9, 36.1, 35.3, 35.0, 34.6, 31.3 (x2), 30.9, 29.7, 28.1, 
26.4, 26.2, 24.1 (C-19), 23.3, 21.4 (-COCH3), 21.4 (-COCH3), 20.7, 18.3 (C-21), 14.3 (-
OCH2CH3), 12.0 (C-18). HRMS: [M + Na]
+ Calcd. C30H48NaO6 527.3349. Found: 
C30H48NaO6 527.3352. 
Ethyl 6-Acetoxy hyodeoxycholate (10): Yield 83% after two purifications by column 
chromatography; colorless oil; 1H NMR (CDCl3, 500 MHz) 5.13 (1H, dt, J = 11.6, 4.8 
Hz, H-6), 4.12 (2H, q, J = 6.8 Hz, -OCH2CH3), 3.60 (1H, tt, J = 11.2, 6.5 Hz, H-3), 2.32 
(1H, m, H-23b), 2.21 (1H, m, H-23a), 2.02 (3H, s, -COCH3), 1.26 (3H, t, J = 6.8 Hz, -
OCH2CH3), ), 0.96 (3H, s, H-19), 0.92 (3H, d, J = 6.5 Hz, H-21), 0.64 (3H, s, H-18); 
13C 
NMR (CDCl3, 500 MHz) 174.3 (C-24), 170.5 (-COCH3), 71.3 (C-3, C-6), 60.2 (-
OCH2CH3), 56.1, 55.9, 45.3, 42.9, 39.9 (x2), 36.1, 35.3 (x2), 34.7, 31.3 (x2), 30.9, 30.3, 
30.1, 28.1, 24.1 (C-19), 23.3, 21.4 (-COCH3), 20.7, 18.3 (C-21), 14.3 (-OCH2CH3), 12.0 
(C-18). HRMS: [M + Na]+ Calcd. C28H46NaO5 485.3243. Found: C28H46NaO5 485.3246. 
 
3. Results and Discussions 
3.1. Enzymatic Esterification 
According to literature, only methyl and ethyl esters of hyodeoxycholic acid have been 
described so far, which were prepared using methanol or ethanol and sulphuric acid [39, 
40]. 
Searching for a mild alternative procedure for obtaining different esters of HDCA, we 
performed the lipase-catalyzed esterification of this acid, using different alcohols (Scheme 
2). In order to optimize the reaction conditions we made several experiments, including a 
lipase screening and variation of other reaction parameters such as temperature, solvent, 
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enzyme:substrate ratio (E/S) and alcohol:substrate ratio (Nu/S) using ethanol as model 
nucleophile. 
 
 
Scheme 2. Enzymatic synthesis of hyodeoxycholic esters. 
 
In the beginning, we studied the behavior of lipases from several sources in the reaction of 
5 with ethanol: from the yeasts Candida rugosa (CRL) and Candida antarctica B (CAL B), 
Lipozyme from the fungus Rhizomucor miehei (LIP) and Thermomyces lanuginosus 
(TLIM). Also from plants: the naturally immobilized Carica papaya lipase (CPL), which is 
the remaining solid fraction of papaya latex after washing off proteases. 
In lipase-catalyzed reactions it is complicated to predict the effect of solvent because it 
depends on the substrate used [21, 24]. Therefore to choose an appropriate solvent, 
screening experiments are made. The solvents evaluated were hexane, diisopropyl ether 
(DIPE), t-butanol and acetone. In addition, the reaction using ethanol both as nucleophile 
and solvent was also performed. Taking into account the optimal reaction conditions for 
similar transformations, the reactions were carried out at 55 °C using E/S: 10 and 
nucleophile:substrate ratio Nu/S: 10 [36, 37]. 
Among the enzymes evaluated, LIP and CAL B were the best lipases toward the 
esterification of HDCA. With CRL, CPL, TLIM or in the absence of biocatalyst no product 
was obtained. In terms of conversion, both LIP and CAL B proved to be more efficient than 
the other evaluated lipases, being equally efficacious affording 6a (100% conversion) at 72 
h of reaction. But taking into account that LIP is significantly cheaper than CAL B, LIP 
was the enzyme of choice. Both lipases were more active in DIPE than in the other solvents 
tested, as shown in the Figure 1. 
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Figure 1. Effect of solvent for esterification of HDCA (5) with the most effective lipases 
evaluated.  
 
 
 
 
 
 
 
Figure 2. Result from the E/S screening experiments showing optimal ratio for LIP. 
 
Then, the influence of E/S in the enzymatic esterification was evaluated using Nu/S: 10, 
DIPE as solvent at 55 °C and variable amounts of LIP (Figure 2). From the obtained 
results, it can be seen that 100% conversion was achieved even at E/S = 0.5 after 72 hs of 
reaction. LIP showed a superb efficiency for this reaction, since this value of E/S is very 
low in comparison with previous work [36, 37]. Considering the results schematized in the 
figure 2, E/S = 0.5 was the ratio of choice. 
The influence of Nu/S on esterification yield was also evaluated at 72 h in DIPE using LIP 
(E/S 0.5) at 55 °C. We have observed that an equimolar ratio was enough to achieve the 
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best results. Lastly, in order to analyze the influence of temperature, the reaction was 
carried out at 25 °C, 40 °C and 55 ºC, keeping the rest of the reaction parameters at their 
optimal values (LIP, DIPE, E/S: 0.5 and Nu/S: 1). Maximum conversion was reached at 55 
°C after 72 h. At lower temperatures a decrease in conversion percentages was observed at 
the same reaction time. In addition, methyl t-butyl ether (MTBE) was used as reaction 
solvent at 25 °C and 40 °C. However, yields were lower than those with DIPE at 55 °C. 
Therefore, 55 °C was selected as the optimum temperature.  
Based on these results, the optimal conditions for the enzymatic esterification of 
hyodeoxycholic acid are: LIP as biocatalyst, DIPE as solvent, temperature: 55 °C, E/S: 0.5 
and Nu/S: 1.0. 
It is interesting to note that towards biocatalytic esterification, HDCA behaves differently 
in comparison to other dihydroxylated bile acids previously studied, whereas its reactivity 
is similar to cholic acid (CA) [36, 37]. In the case of chenodeoxycholic acid (CDCA) and 
deoxycholic acid (DCA), CAL B was the best biocatalyst and the conditions involved E/S: 
10, Nu/S: 5, hexane as solvent and a temperature of 55 °C. On the other hand, the optimal 
conditions for esterification of CA were LIP as biocatalyst, temperature: 40 °C, E/S: 10, 
Nu/S: 20 and DIPE as solvent.  
 
Table 1. Enzymatic synthesis of hyodeoxycholic esters. 
    
Entry Nucleophile Product Yield (%) 
1 CH3CH2OH 6a 95 
2 CH3CH2CH2OH 6b 90 
3 CH3(CH2)2CH2OH 6c 82 
4 CH3(CH2)3CH2OH 6d 80 
5 CH3(CH2)6CH2OH 6e 78 
6 CH3(CH2)10CH2OH 6f 83 
7 CH3(CH2)12CH2OH 6g 85 
8 CH3(CH2)14CH2OH 6h 82 
9 CH3(CH2)16CH2OH 6i 80 
10 PhCH2OH 6j 92 
Reaction conditions: Enzyme: LIP; Solvent: DIPE; Temperature: 55 °C; E/S: 0.5 Nu/S: 1 
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Once the experimental conditions were optimized, we applied them to the esterification of 5 
with a variety of alcohols to afford products 6a-j. The results, expressed as yield of isolated 
product, are summarized in Table 1. 
Alkyl esters containing linear alkyl chains from two to eighteen carbon atoms were 
synthesized in very good to excellent yield (78-95 %). A relation was not observed between 
yield and alkyl chain length as in the case of cholic acid. Every product was completely 
characterized by spectroscopic methods and seven of them (6b-6h) were not previously 
described in literature. The use of an equivalent amount of alcohol makes this procedure 
even more advantageous, especially in the case of longer-chain derivatives in terms of 
product isolation, process simplicity and economy.  
 
3.2. Enzymatic Acetylation 
To the best of our knowledge, monoacetyl derivatives of hyodeoxycholic acid have not 
been described so far. Similarly to other bile acids, bisacetylation of HDCA was carried out 
at room temperature in acetic anhydride, DMAP and pyridine. 
Recently, we have reported the synthesis of 3-acetyl derivatives of chenodeoxycholic and 
deoxycholic acid using CAL B as biocatalyst. Under the same reaction conditions, with 
lithocholic acid as substrate, the lipase catalyzed both the acetylation and esterification 
reactions affording ethyl lithocholate 3-acetate as the only product in one pot-two steps 
[36]. In addition, it was not possible to acetylate cholic acid in a regioselective way, 
chemically or enzymatically. However, the ethyl ester of cholic acid was enzymatically 
acetylated on a regioselective way affording 3-acetyl derivative [37]. 
Therefore, we sought a regioselective enzymatic acetylation of hyodeoxycholic acid 
(Scheme 3). We began by applying the optimal conditions determined for the acetylation of 
CDCA and DCA: CAL B as biocatalyst, ethyl acetate as acylating agent, E/S: 5, A/S: 5 in 
hexane at 55 °C. In addition, we carried out the reaction using ethyl acetate both as solvent 
and acylating agent. The 3-acetyl derivative (7) was obtained in both cases in excellent 
yield after 1 h of reaction. The lipase showed a fully regioselective behavior, reacting only 
with the hydroxyl moiety on carbon 3, leaving the one on carbon 6 unscathed under the 
evaluated conditions. 
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Scheme 3. Enzymatic synthesis of acetyl derivatives of HDCA (5) and ethyl ester (6a). 
 
Taking into account that 100% of conversion was observed for the HDCA under the 
conditions of acetylation for the CDCA, we carried out the reaction with lower E/S ratios:  
the acetylation finished after 3 h using a E/S ratio of 1, and finished after 24 h with a E/S 
ratio of 0.5. The low amount of enzyme necessary for catalyzing the acetylation reaction 
confers an additional advantage to this enzymatic methodology.  
The same conditions (CAL B, ethyl acetate, hexane, E/S: 0.5, A/S: 5, 55 °C) were used to 
carry out acetylation of ethyl ester 6a. Again, we observed acetylation of hydroxyl group on 
3-position, obtaining the corresponding ethyl ester 3-acetate (8) after 8 h of reaction. The 
acetylation of HDCA was also tested in the presence of LIP as biocatalyst but no 
conversion was observed after 24 h of reaction. 
It is also important to note the significant difference in the reaction time of acetylation of 
HDCA compared to that for CDCA and DCA. While the compound 7 was obtained after 1 
h of reaction, the 3-acetate derivatives of the other bile acids were obtained in 48 h. If the 
reaction mixture is left stirring five days, esterification also occurs, obtaining ethyl 3-acetyl 
hyodeoxycholate (8). These results suggest that it is not possible to acetylate the 6-position 
applying this methodology and, on the other hand, the ethanol generated in the reaction was 
capable to esterify the carboxylic acid moiety given enough time. We had already observed 
the same behavior in the case of CAL B catalyzed acetylation of lithocholic acid (LCA) 
[36]. 
On the other hand, it is important to remark the considerable difference observed in the 
reaction times for acetylation (1 h) compared to esterification (72 h) of HDCA. 
 
3.3. Enzymatic Alcoholysis 
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In order to obtain the 6-acetyl derivative of HDCA we carried out bisacetylation of both 
HDCA and its ethyl ester, followed by enzymatic alcoholysis. Products of peracetylacion, 
9a and 9b, were obtained respectively in 89 % and 85% yield, treating 5 and 6a with acetic 
anhydride and pyridine at room temperature during 16 h (Scheme 4). 
 
 
Scheme 4. Chemical synthesis and enzymatic alcoholysis of peracetylated derivatives of 
HDCA (5) and the ethyl ester (6a). 
 
We carried out the enzymatic alcoholysis of 9a and 9b applying the optimal conditions 
determined for alcoholysis of peracetylated chenodeoxycholic acid: CAL B as biocatalyst 
(E/S: 5) ethanol as nucleophile (Nu/S: 1.2), hexane as solvent, temperature: 55 °C [36]. For 
both substrates the used lipase was regioselective, reacting only at 3-position. Using these 
conditions, we obtained ethyl 6-acetyl hyodeoxycholate (10) from 9b in excellent yield 
(89%) after 2 h of reaction (Scheme 3). As observed in previous work [36, 37] , starting 
from 9a, the alcoholysis reaction also afforded 10 (92% yield), using ethanol as both 
alcoholysis and esterifying agent. In this case, at shorter reaction times it was observed the 
formation of a compound in very low proportion, which quickly becomes the reaction 
product 10. Probably this intermediate compound corresponds to the 6-acetyl 
hyodeoxycholic acid, which is immediately esterified. In both cases CAL B behaved 
regioselectively, as in acetylation reactions, providing an efficient alternative to obtain the 
derivative without altering the 6-position, agreeing with previous work of our laboratory 
[26, 36, 41, 42]. 
 
 
4. Conclusions 
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This work describes the synthesis of hyodeoxycholic acid derivatives, most of them new 
compounds in a regioselective way, using enzymes as catalysts. By this methodology, we 
were able to accurately control the reaction, obtaining very good conversions rapidly and, 
in most cases, only one product. Furthermore, the catalyst is removed by a mere filtration 
step and can be reused, retaining excellent activity after five reaction cycles. 
Amongst the various reaction parameters analyzed for each reaction, we tested different 
lipases, obtaining the best results with both Candida antarctica B and Lipozyme from 
Rhizomucor miehei for esterification reactions. Given that LIP is cheaper than CAL B, and 
thus considering the overall reaction applicability we bent towards the use of LIP to esterify 
this bile acid. 
For both acetylation and alcoholysis the enzyme of choice was CAL B, since LIP showed 
no activity for those reactions. 
To sum up, not only we present the synthesis of several new compounds from a substrate 
that has been avoided for many years, but also we make it in a simple, environmentally 
friendly way and the reactions are efficiently performed at mild temperature and are 
purified easily. 
 
Supporting Information. Spectral data for compounds 6-10 associated with this article are 
supplied. 
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Highlights 
 
 Hyodeoxycholic acid derivatives were prepared by an enzymatic approach in a 
regioselective way. 
 The influence of several parameters was considered. 
 The lipase catalysis was a very efficient procedure, especially considering the low 
amount used. 
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Scheme 1. Structure of important bile acids. 
Scheme 2. Enzymatic synthesis of hyodeoxycholic alkyl esters. 
Figure 1. Effect of solvent for esterification of HDCA (1) with the most effective lipases 
evaluated. 
Figure 2. Results from the E/S screening experiments, showing optimal relation for LIP. 
Scheme 3. Enzymatic synthesis of acetyl derivatives of HDCA (1) and ethyl ester (2a). 
Scheme 4. Chemical synthesis and enzymatic alcoholysis of peracetylated derivatives of 
HDCA (1) and the ethyl ester (2a). 
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Scheme 2 
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Scheme 3 
  
  
30 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1. Enzymatic synthesis of hyodeoxycholic esters. 
    
Entry Nucleophile Product Yield (%) 
1 CH3CH2OH 6a 95 
2 CH3CH2CH2OH 6b 90 
3 CH3(CH2)2CH2OH 6c 82 
4 CH3(CH2)3CH2OH 6d 80 
5 CH3(CH2)6CH2OH 6e 78 
6 CH3(CH2)10CH2OH 6f 83 
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7 CH3(CH2)12CH2OH 6g 85 
8 CH3(CH2)14CH2OH 6h 82 
9 CH3(CH2)16CH2OH 6i 80 
10 PhCH2OH 6j 92 
Reaction conditions: Enzyme: LIP; Solvent: DIPE; Temperature: 55 °C; E/S: 0.5 Nu/S: 1 
 
 
